Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease—the ASSUAGE-CKD trial
- DOI
- 10.1007/s10554-012-0166-6
- Published
- 2012-12-11
- Container
- The International Journal of Cardiovascular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10554-012-0166-6,
title = {Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease—the ASSUAGE-CKD trial},
author = {Rami Doukky and Maria Octavia Rangel and Rizcallah Dick and Marwan Wassouf and Ammar Alqaid and Bosko Margeta},
year = {2012},
journal = {The International Journal of Cardiovascular Imaging},
doi = {10.1007/s10554-012-0166-6},
url = {https://doi.org/10.1007/s10554-012-0166-6}
}RIS
TY - JOUR TI - Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease—the ASSUAGE-CKD trial AU - Rami Doukky AU - Maria Octavia Rangel AU - Rizcallah Dick AU - Marwan Wassouf AU - Ammar Alqaid AU - Bosko Margeta PY - 2012 JO - The International Journal of Cardiovascular Imaging DO - 10.1007/s10554-012-0166-6 UR - https://doi.org/10.1007/s10554-012-0166-6 ER -
APA
Doukky, R., Rangel, M. O., Dick, R., Wassouf, M., Alqaid, A., & Margeta, B. (2012). Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease—the ASSUAGE-CKD trial. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-012-0166-6
Source records
- crossref · retrieved 2026-09-27T02:29:16.687Z